Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's After-Market Session

Author: Benzinga Insights | February 03, 2022 04:57pm

Gainers

  • Cidara Therapeutics (NASDAQ:CDTX) stock moved upwards by 14.1% to $0.91 during Thursday's after-market session. The company's market cap stands at $60.6 million.
  • Biophytis (NASDAQ:BPTS) shares increased by 6.99% to $4.74. The market value of their outstanding shares is at $61.1 million.
  • Spectrum Pharmaceuticals (NASDAQ:SPPI) stock increased by 6.74% to $0.67. The market value of their outstanding shares is at $117.8 million.
  • Trevena (NASDAQ:TRVN) shares rose 5.0% to $0.5. The market value of their outstanding shares is at $82.9 million.
  • Ortho Clinical Diagnostic (NASDAQ:OCDX) shares increased by 4.96% to $18.16. Ortho Clinical Diagnostic's trading volume hit 207.1K shares by close, accounting for 14.3% of its average volume over the last 100 days. The company's market cap stands at $4.3 billion.
  • Provention Bio (NASDAQ:PRVB) stock rose 4.95% to $5.3. This security traded at a volume of 75.9K shares come close, making up 7.3% of its average volume over the last 100 days. The company's market cap stands at $335.8 million.

Losers

  • Lannett (NYSE:LCI) shares fell 20.6% to $1.14 during Thursday's after-market session. This security traded at a volume of 69.6K shares come close, making up 14.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $49.3 million. As per the press release, Q2 earnings came out today.
  • Syros Pharmaceuticals (NASDAQ:SYRS) shares decreased by 2.8% to $1.74. The company's market cap stands at $107.7 million.
  • Pasithea Therapeutics (NASDAQ:KTTA) stock fell 2.57% to $1.14. The company's market cap stands at $24.9 million.
  • Aridis Pharmaceuticals (NASDAQ:ARDS) shares declined by 2.39% to $2.05. The company's market cap stands at $28.8 million.
  • OpGen (NASDAQ:OPGN) stock declined by 2.19% to $0.87. The company's market cap stands at $40.4 million.
  • Epizyme (NASDAQ:EPZM) stock decreased by 2.18% to $1.35. The market value of their outstanding shares is at $219.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ARDS BPTS CDTX EPZM KTTA LCI OCDX OPGN PRVB SPPI SYRS TRVN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist